Literature DB >> 11092203

Vascular function in systemic sclerosis.

A L Herrick1.   

Abstract

Raynaud phenomenon is often the earliest manifestation of systemic sclerosis. This fact highlights the role of vascular dysfunction early on in the disease process. Although this review deals primarily with digital vasculature, recent research confirms that vascular dysfunction is widespread, and affects large as well as small vessels. Abnormalities of vascular function and structure are interdependent, and together result in the ischemic atrophy so characteristic of SSc. Key areas of research include the pathophysiology of the imbalance between vasodilation and vasoconstriction, with particular interest in understanding the relative contributions of endothelial-dependent and endothelial-independent vasodilation, and the development of new methodologies by which to quantify vascular function.

Entities:  

Mesh:

Year:  2000        PMID: 11092203     DOI: 10.1097/00002281-200011000-00009

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  21 in total

1.  The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function.

Authors:  Alma Cypiene; Aleksandras Laucevicius; Algirdas Venalis; Jolanta Dadoniene; Ligita Ryliskyte; Zaneta Petrulioniene; Milda Kovaite; Jonas Gintautas
Journal:  Clin Rheumatol       Date:  2008-07-25       Impact factor: 2.980

2.  Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats.

Authors:  S Blaise; M Roustit; C Millet; C Ribuot; J Boutonnat; J L Cracowski
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis.

Authors:  Marieta P Theodorakopoulou; Ioanna Minopoulou; Pantelis Sarafidis; Vassilios Kamperidis; Christodoulos Papadopoulos; Theodoros Dimitroulas; Afroditi K Boutou
Journal:  Rheumatol Int       Date:  2021-04-08       Impact factor: 2.631

4.  Nonenhanced MR angiography of the hand with flow-sensitive dephasing-prepared balanced SSFP sequence: initial experience with systemic sclerosis.

Authors:  John J Sheehan; Zhaoyang Fan; Amir H Davarpanah; Philip A Hodnett; John Varga; James C Carr; Debiao Li
Journal:  Radiology       Date:  2011-02-17       Impact factor: 11.105

5.  Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis.

Authors:  Matthieu Roustit; Grant H Simmons; Jean-Philippe Baguet; Patrick Carpentier; Jean-Luc Cracowski
Journal:  J Rheumatol       Date:  2008-06-15       Impact factor: 4.666

6.  Mistaken identity: normotensive scleroderma renal crisis.

Authors:  Arwa Aburizik; Siddharth Singh; Laith Al-Rabadi; Christopher Blosser
Journal:  BMJ Case Rep       Date:  2014-05-29

7.  Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis.

Authors:  Paola Coral-Alvarado; Gerardo Quintana; Maria Fernanda Garces; Libia Alexandra Cepeda; Jorge Eduardo Caminos; Federico Rondon; Antonio Iglesias-Gamarra; Jose Felix Restrepo
Journal:  Rheumatol Int       Date:  2008-12-31       Impact factor: 2.631

Review 8.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

9.  Hearing loss in patients with scleroderma: associations with clinical manifestations and capillaroscopy.

Authors:  S Shenavandeh; S B Hashemi; MahmoodReza Masoudi; M A Nazarinia; A Zare
Journal:  Clin Rheumatol       Date:  2018-06-02       Impact factor: 2.980

10.  Improvements in digital vasculature observed using micro magnetic resonance angiography after high-dose immunosuppression for severe systemic sclerosis.

Authors:  J Wang; R A Nash; B Chu; V L Yarnykh; S M Schwartz; K M Sullivan; C Yuan
Journal:  Bone Marrow Transplant       Date:  2009-03-02       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.